FDA Drug Application (022165) for CAMBIA by DEPOMED INC

Back to FDA Applications sponsored by DEPOMED INC

Application Number022165
Product Number001
FormFOR SOLUTION;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCAMBIA
Active IngredientDICLOFENAC POTASSIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOFENAC POTASSIUM4


Back to FDA Applications sponsored by DEPOMED INC